TECHNOLOGIES

Innovative technologies are the key to the future. Join us on this path

Recombinant proteins/mABs

From discovery to pilot production: YURiA-PHARM performs full-cycle development of recombinant protein-based therapeutics.
Read more

RNA therapeutics

YURiA-PHARM is developing a technological platform for the production of next-generation gene therapies based on mRNA in situ amplification technology.
Read more

Biopolymer gels/Hyaluronic Acid

We produce safe and effective solutions for injectable implants based on hyaluronic acid and other biopolymers.
Read more

Nanoparticles for API delivery

The synthesis of polymer particles for the delivery of active pharmaceutical ingredients involves thorough optimization and control of their physical and chemical parameters.
Read more

Organic synthesis

We have experience in the development of methods for the synthesis and purification of API that comply with international quality standards.
Read more

Inhalations

Inhalation solutions and suspensions, dry powder inhalations and nasal sprays - we are developing inhalation products for targeted delivery and improved bioavailability of API.
Read more

Parenteral powders

We develop parenteral powders as an alternative to solutions to increase stability and shelf-life of complex and easily degradable active substances.
Read more

Parenteral solutions and emulsions

Solutions and emulsions for parenteral use have been our specialization over a long time. Quality of the API, the water used, and the packaging remain our main technological objectives.
Read more